Coloplast A/S - ESG Rating & Company Profile powered by AI
The Disclosure rating includes seventeen United Nations Sustainable Development Goals including: 'Affordable & Clean Energy', 'Industry, Innovation & Infrastructure' and 'Peace, Justice & Strong Institutions'. This SDG score for Coloplast A/S indicates the company's transparency towards the UN Sustainable Development Goals. This report of Coloplast A/S was prepared by All Street Sevva using cutting edge artificial intelligence.
Coloplast A/S in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 6.6; made up of an environmental score of 8.0, social score of 6.0 and governance score of 5.7.
6.6
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
84 | Surgical Innovations Group PLC | 6.7 | High |
84 | Scandinavian Real Heart AB | 6.7 | High |
92 | Coloplast A/S | 6.6 | High |
92 | Carefusion Corp | 6.6 | High |
92 | AxoGen Inc | 6.6 | High |
... | ... | ... | |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Coloplast A/S have an accelerator or VC vehicle to help deliver innovation?
Does Coloplast A/S disclose current and historical energy intensity?
Does Coloplast A/S report the average age of the workforce?
Does Coloplast A/S reference operational or capital allocation in relation to climate change?
Does Coloplast A/S disclose its ethnicity pay gap?
Does Coloplast A/S disclose cybersecurity risks?
Does Coloplast A/S offer flexible work?
Does Coloplast A/S have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Coloplast A/S disclose the number of employees in R&D functions?
Does Coloplast A/S conduct supply chain audits?
Does Coloplast A/S disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Coloplast A/S conduct 360 degree staff reviews?
Does Coloplast A/S disclose the individual responsible for D&I?
Does Coloplast A/S disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Coloplast A/S disclose current and / or historical scope 2 emissions?
Does Coloplast A/S disclose water use targets?
Does Coloplast A/S have careers partnerships with academic institutions?
Did Coloplast A/S have a product recall in the last two years?
Does Coloplast A/S disclose incidents of discrimination?
Does Coloplast A/S allow for Work Councils/Collective Agreements to be formed?
Has Coloplast A/S issued a profit warning in the past 24 months?
Does Coloplast A/S disclose parental leave metrics?
Does Coloplast A/S disclose climate scenario or pathway analysis?
Does Coloplast A/S disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Coloplast A/S disclose the pay ratio of women to men?
Does Coloplast A/S support suppliers with sustainability related research and development?
Does Coloplast A/S disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Coloplast A/S reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Coloplast A/S involved in embryonic stem cell research?
Does Coloplast A/S disclose GHG and Air Emissions intensity?
Does Coloplast A/S disclose its waste policy?
Does Coloplast A/S report according to TCFD requirements?
Does Coloplast A/S disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Coloplast A/S disclose energy use targets?
Does Coloplast A/S disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Coloplast A/S have a policy relating to cyber security?
Have a different question?
Potential Risks for Coloplast A/S
These potential risks are based on the size, segment and geographies of the company.
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.